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Aim of the study. To determine whether metformin is more effective in weight loss after the 
use of antipsychotic medications.  
Materials and methods. PubMed database was used to search meshterms “antipsychotic, 
weight gain, metformin,” which were combined with “and” to result in 14 articles. After the 
addition of the filter “published within the last 5 years” was added, 5 articles were left. The 
meshterms “antipsychotic, weight gain, naltrexone” were combined with “and” to result in 3 
articles. There were no articles with both drugs together.  Embase database was searched from 
1996 till 2017 week 02. Mapped key words “antipsychotic, weight gain, naltrexone” were 
filtered with randomized controlled trials within the last 5 years and combined with “and” 
which resulted in one article. Similarly key words “antipsychotic, weight gain, metformin” 
resulted in 5 articles. Two articles were not on the correct topic.  
Results. Metformin is shown to significantly reduce weight in schizophrenic patients by about 
3 kg (2 RCTs; n=148, 45 women; and n=72, 32 women). Second study shows that metformin 
reduced initial body weight greater than was clinically significant (>7%, p=0.003). Naltrexone 
showed significant weight loss of 3.4 kg (CI=-5.16, -1.65, p=0.001) (1 RCT; n=24). No studies 
compared metformin and naltrexone in one trial. Metformin was shown to have more additional 
health benefits.  
Conclusions. Both metformin and naltrexone show statistically significant weight reduction in 
patients taking antipsychotics. However, metformin appears in more studies than naltrexone 
and shows additional health benefits like reduction of triglycerides. Thus, metformin appears 
to be more effective in weight control for women with schizophrenia. Pharmacists might be 
able to recommend metformin as an adjunct to the antipsychotic therapy.  
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Introduction. Gastro-duodenum ulcer is a break in the inner lining of the stomach, the first 
part of the small intestine, or sometimes the lower esophagus. The most common symptoms of 
a duodenal ulcer are waking at night with upper abdominal pain (often described as a burning 
or dull ache), belching, vomiting, weight loss, or poor appetite. Worldwide, prevalence of the 
disease is estimated at 6-14% of the adult population and for Republic of Moldova is 100-120 
sick persons per 10,000 population  
Aim of the study. Highlighting epidemiological factors, mechanism of development and 
treatment methods of gostro-duodenum ulcer  
Materials and methods. Analysis of data from the observation files of 60 patients hospitalized 
in Internal Diseases Department no.1 of "Clinical Hospital of the Ministry of Health", 
Gastrology unit, during 2019. The evaluated parameters were: gender, age, smoker or non-
smoker, place of living, basic diagnosis (type of ulcer developed), the etiology of the disease, 
complications, treatment, recommendations for discharge  
Results. The analysis of the distribution of cases of gastro-duodenum ulcer by sex showed the 
predominance of the male (62%) compared to the female (38%). The total number of patients 
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diagnosed with gastric or duodenal ulcer disease rate was distributed as follows: 90% of 
patients developed duodenal ulcers and 10% - developed gastric ulcers. The treatment included: 
spasmolytics (100%), chemotherapics (80%), proton pump inhibitors and antibiotics (67%), 
H2 receptor antagonists (37%), antacids (22%), gastroprotectives (11%). The other medicinal 
remedies were indicated for symptomatic purpose: hemostatics (12%), prokinetics (5%), 
sedatives (58%)  
Conclusions. 1. Gastric and duodenal ulcer is a defect of the gastric or duodenal mucosa, which 
goes far beyond the muscular mucosa and is surrounded by an acute or chronic inflammatory 
infiltrate.  2. The most important factors that modulate the epidemiology of gastric and 
duodenal ulcer are genetic predisposition, Helicobacter Pylori infection (decreasing) and 
consumption of NSAIDs (increasing).  3. In our study, men are more often affected, because 
they are more frequently subjected to risk factors, such as: active and passive smoking, alcohol 
use, food additives and psycho-emotional pressure.  
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Introduction. Gout is a chronic condition caused by the disorder of uric acid metabolism, 
which is manifested clinically, first of all, by acute relapsing arthritis and the formation of 
subcutaneous gouty nodules (tofi), formed from accumulations of microcrystals of 
monosodium urate monohydrate. In the Republic of Moldova, gout is determined in 2.5% of 
the population with asymptomatic hyperuricemia, but the morbidity varies from 0.3 to 2.1%.  
Aim of study. The elucidation of clinical features and contemporary principles of 
pharmacotherapy and monitoring of gout medication.  
Materials and methods. We investigated 74 patients with different clinical forms of gout that 
were hospitalized during 2019 in the Rheumatology Unit of the Republican Clinical Hospital. 
Results. The prevalence by age is found in men between 51-60 years old (37.8%) and among 
women at 61-70 years old (4.1%). Gout is most often reported among men (93.2%), which is 
related to alcohol and food abuse (meat, beef, tomatoes); traumatic events, hunger and stress. 
According to the observation sheets, patients most frequently present a period of illness and/or 
worsening of the health status in the last years: 33.8% - up to 5 years and 31% - 6-10 years. 
There is a higher incidence of chronic tophi gout (56.8%) and idiopathic chronic gout (35.1%), 
which makes us conclude that patients addressed after specialized medical help in the hospital   
only in case of worsening health, other gout attacks. being monitored by the family doctor in   
ambulatory conditions. For the treatment of acute gout attacks and for their prevention more   
frequently is used uricodepressive treatment with: Alopurinol (95.9%), Colchicine (32.4%), 
Canefron (47.3%), analgesic treatment with antipyretic analgesics (39.2%), nonsteroidal anti-   
inflammatory drugs (87.8%) and corticosteroids (16.2%). The average bed days spent by the 
patients in   the Rheumatology Unit is 8 days. According to the observation sheets, it was 
established that during the winter-spring period, 58.11% of the total number of patients were 
undergoing treatment in hospital, which can be caused by the worsening of the disease during 
the cold period or by the oscillations of the temperature during spring. 
